Vaccines for Papillomavirus (HPV) Infection
نویسندگان
چکیده
منابع مشابه
Vaccines for Papillomavirus (HPV) Infection
Prophylactic HPV vaccination of both quadrivalent and bivalent vaccines has already been approved in Spain and is gaining popularity among Spanish women. Other European countries show similar trends. With the use of vaccines against HPV, especially the tetravalent vaccine, in the short or medium-term there will be a lower rate of abnormal cytological results in vaccinated women, which is based ...
متن کاملHuman papillomavirus (HPV) vaccines
Kinoshita et al. 2014 48 patients (from same clinic as above and largely overlapping time period). 18 fulfilling the diagnostic criteria for CRPS-1. Abstract /Kinoshita et al, 2014 17 patients from an unknown time period. -Kinoshita et al, 2014 17 patients from an unknown time period. Letter to the editor / 2 adolescents Both patients fulfilled the fibromyalgia criteria and were 22 Richards et ...
متن کاملVaccines for papillomavirus infection.
Vaccines to prevent PV infection, utilising PV L1 virus like particles (VLPs) to induce neutralising antibody, are in clinical trial and show all the characteristics likely to be associated with success. Results warrant global planning for the deployment of VLP vaccines within a decade, as part of a program to prevent cervical cancer. Vaccines designed to treat existing PV infection by inducing...
متن کاملHuman papillomavirus and HPV vaccines: a review.
Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with "high-risk" genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70% of all cervical cancers. Types 6 and 11 do not contribute to the incidence of high-grade dysplasias (precancerous lesions) or cervical cancer...
متن کاملVaccines against rotavirus and human papillomavirus (HPV).
OBJECTIVE To briefly review strategies aimed at the development of rotavirus and HPV vaccines, with emphasis on the current status of studies assessing the safety, reactogenicity, immunogenicity and efficacy of recently developed vaccines. SOURCES OF DATA This review focuses on articles published from 1996 to 2006, mainly those from the last five years, with special emphasis on data obtained ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Open Dermatology Journal
سال: 2009
ISSN: 1874-3722
DOI: 10.2174/1874372200903010129